BeOne Medicines

ONCNasdaq Cayman Islands Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$41.577 B

$365.67 +4.23%

Close of 21 Sept 2026

Revenue

$5.34B

#638 by revenue

Earnings

$286.9M

#858 by earnings

Shares outstanding

1,478,124,405

Latest filing cover page

P/E ratio

144.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#15Takeda PharmaceuticalTAK$59.7B
#16Teva Pharmaceutical IndustriesTEVA$46.7B
#17BeOne MedicinesONC$41.6B
#18Royalty PharmaRPRX$33.6B
#19Alnylam PharmaceuticalsALNY$32.7B

What if BeOne Medicines were worth as much as…

Open the what-if tool →

Gold $30.3T

$266,258.17

Per share 728× higher

Bitcoin $1.72T

$15,125.55

Per share 41.4× higher

Nvidia $5.48T

$48,194.97

Per share 132× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for BeOne Medicines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.